BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

15036

210290

INFINIUM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

INFINIUM PHARMACHEM LTD performance

Today’s low

Today’s high

₹ 296.00 ₹ 307.00
₹ 296.80

52 week low

52 week high

₹ 178.05 ₹ 392.50
₹ 296.80

Open Price

₹ 306.50

Prev. Close

₹ 299.00

Volume (Shares)

10000.00

Total traded value

₹ 29.68

Upper Circuit

₹ 313.95

Lower Circuit

₹ 284.05

info

INFINIUM PHARMACHEM LTD Share Price Update

As of the latest trading session, INFINIUM PHARMACHEM LTD share price is currently at ₹ 296.8, which is down by ₹ -2.20 from its previous closing. Today, the stock has fluctuated between ₹ 296.00 and ₹ 307.00. Over the past year, INFINIUM PHARMACHEM LTD has achieved a return of 34.90 %. In the last month alone, the return has been 24.18 %. Read More...

INFINIUM PHARMACHEM LTD fundamentals


  • Market cap (Cr)

    413.03

  • P/E Ratio (TTM)

    41.69

  • Beta

    0.77

  • Book Value / share

    63.43

  • Return on equity

    27.91%

  • EPS (TTM)

    7.12

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text
  • Market cap (Cr)

    0.0

  • P/E Ratio (TTM)

    0.0

  • Beta

    0.0

  • Book Value / share

    0.0

  • Return on equity

    0.0%

  • EPS (TTM)

    0.0

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.0

info icon alternate text

INFINIUM PHARMACHEM LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 122.36
Operating Expense 109.13
Net Profit 11.09
Net Profit Margin (%) 9.06
Earnings Per Share (EPS) 7.97
EBITDA 19.05
Effective Tax Rate (%) 25.37
Particulars MAR 2023 (Values in Cr)
Revenue 101.31
Operating Expense 90.39
Net Profit 9.15
Net Profit Margin (%) 9.03
Earnings Per Share (EPS) 18.00
EBITDA 16.55
Effective Tax Rate (%) 25.44
Particulars MAR 2022 (Values in Cr)
Revenue 74.04
Operating Expense 67.56
Net Profit 5.50
Net Profit Margin (%) 7.42
Earnings Per Share (EPS) 54.13
EBITDA 9.65
Effective Tax Rate (%) 25.64
Particulars MAR 2021 (Values in Cr)
Revenue 54.56
Operating Expense 51.41
Net Profit 2.72
Net Profit Margin (%) 4.98
Earnings Per Share (EPS) 26.75
EBITDA 5.53
Effective Tax Rate (%) 27.65
Particulars MAR 2020 (Values in Cr)
Revenue 36.04
Operating Expense 35.22
Net Profit 1.02
Net Profit Margin (%) 2.83
Earnings Per Share (EPS) 10.01
EBITDA 3.20
Effective Tax Rate (%) 26.61
Particulars MAR 2024 (Values in Cr)
Book Value / Share 42.24
ROE % 28.28
ROCE % 28.57
Total Debt to Total Equity 0.50
EBITDA Margin 14.80
Particulars MAR 2023 (Values in Cr)
Book Value / Share 44.39
ROE % 55.06
ROCE % 36.74
Total Debt to Total Equity 1.45
EBITDA Margin 15.23
Particulars MAR 2022 (Values in Cr)
Book Value / Share 128.88
ROE % 66.43
ROCE % 38.89
Total Debt to Total Equity 1.64
EBITDA Margin 11.06
Particulars MAR 2021 (Values in Cr)
Book Value / Share 69.09
ROE % 48.40
ROCE % 32.17
Total Debt to Total Equity 1.72
EBITDA Margin 7.91
Particulars MAR 2020 (Values in Cr)
Book Value / Share 41.78
ROE % 20.47
ROCE % 18.92
Total Debt to Total Equity 2.08
EBITDA Margin 7.88
Particulars MAR 2024 (Values in Cr)
Book Value / Share 41.50
ROE % 27.91
ROCE % 29.32
Total Debt to Total Equity 0.43
EBITDA Margin 15.57
Particulars MAR 2023 (Values in Cr)
Book Value / Share 42.69
ROE % 53.43
ROCE % 36.86
Total Debt to Total Equity 1.42
EBITDA Margin 16.34
Particulars MAR 2022 (Values in Cr)
Book Value / Share 123.45
ROE % 56.12
ROCE % 34.43
Total Debt to Total Equity 1.69
EBITDA Margin 13.03
Particulars MAR 2021 (Values in Cr)
Book Value / Share 69.31
ROE % 47.85
ROCE % 31.75
Total Debt to Total Equity 1.70
EBITDA Margin 10.14
Particulars MAR 2020 (Values in Cr)
Book Value / Share 42.46
ROE % 23.61
ROCE % 19.88
Total Debt to Total Equity 2.05
EBITDA Margin 8.88
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 11.91
Total Assets 85.45
Total Liabilities 85.45
Total Equity 60.23
Share Outstanding 13916120
Price to Book Ratio 5.52
Return on Assets (%) 13.22
Return on Capital (%) 15.81
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.98
Total Assets 70.61
Total Liabilities 70.61
Total Equity 23.78
Share Outstanding 5083060
Price to Book Ratio 0.00
Return on Assets (%) 13.43
Return on Capital (%) 17.9
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.45
Total Assets 58.99
Total Liabilities 58.99
Total Equity 13.92
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 10.34
Return on Capital (%) 16.76
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.98
Total Assets 34.18
Total Liabilities 34.18
Total Equity 7.21
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 7.97
Return on Capital (%) 15.37
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.85
Total Assets 22.44
Total Liabilities 22.44
Total Equity 4.34
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 4.16
Return on Capital (%) 7.07
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.17
Total Assets 77.74
Total Liabilities 77.74
Total Equity 57.75
Share Outstanding 13916120
Price to Book Ratio 5.52
Return on Assets (%) 14.26
Return on Capital (%) 16.89
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.31
Total Assets 60.41
Total Liabilities 60.41
Total Equity 21.69
Share Outstanding 5083060
Price to Book Ratio 0.00
Return on Assets (%) 15.14
Return on Capital (%) 19.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.54
Total Assets 49.05
Total Liabilities 49.05
Total Equity 12.54
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 11.21
Return on Capital (%) 15.69
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.23
Total Assets 30.80
Total Liabilities 30.80
Total Equity 7.04
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 8.82
Return on Capital (%) 15.49
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 20.58
Total Liabilities 20.58
Total Equity 4.31
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 4.94
Return on Capital (%) 7.72
Particulars MAR 2024 (Values in Cr)
Net Income 15.21
Cash from Operations -9.37
Cash from Investing -3.79
Cash from Financing 22.76
Net change in Cash 5.93
Free Cash Flow -5.85
Particulars MAR 2023 (Values in Cr)
Net Income 12.95
Cash from Operations 11.70
Cash from Investing -4.95
Cash from Financing -3.10
Net change in Cash 0.52
Free Cash Flow 19.17
Particulars MAR 2022 (Values in Cr)
Net Income 8.63
Cash from Operations 13.75
Cash from Investing -6.63
Cash from Financing -1.70
Net change in Cash 3.46
Free Cash Flow 18.47
Particulars MAR 2021 (Values in Cr)
Net Income 3.76
Cash from Operations 8.33
Cash from Investing -4.99
Cash from Financing -1.15
Net change in Cash 1.13
Free Cash Flow 13.41
Particulars MAR 2020 (Values in Cr)
Net Income 1.23
Cash from Operations 3.40
Cash from Investing -1.05
Cash from Financing -1.23
Net change in Cash 0.74
Free Cash Flow 4.51
Particulars MAR 2024 (Values in Cr)
Net Income 14.86
Cash from Operations -11.38
Cash from Investing -3.29
Cash from Financing 23.18
Net change in Cash 4.86
Free Cash Flow -8.06
Particulars MAR 2023 (Values in Cr)
Net Income 12.26
Cash from Operations 10.44
Cash from Investing -2.58
Cash from Financing -2.99
Net change in Cash 1.77
Free Cash Flow 15.09
Particulars MAR 2022 (Values in Cr)
Net Income 7.40
Cash from Operations 11.04
Cash from Investing -7.17
Cash from Financing -1.65
Net change in Cash 0.30
Free Cash Flow 15.74
Particulars MAR 2021 (Values in Cr)
Net Income 3.75
Cash from Operations 7.86
Cash from Investing -4.59
Cash from Financing -1.12
Net change in Cash 1.10
Free Cash Flow 12.46
Particulars MAR 2020 (Values in Cr)
Net Income 1.38
Cash from Operations 2.70
Cash from Investing -1.07
Cash from Financing -1.22
Net change in Cash 0.01
Free Cash Flow 3.80
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

INFINIUM PHARMACHEM LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
296.80 -0.73 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 294.00
  • 26 Days 259.50
  • 10 Days 281.10
  • 50 Days 256.30
  • 12 Days 276.60
  • 100 Days 263.30
  • 20 Days 264.40
  • 200 Days 262.40
303.00 PIVOT

First Support

295.00

First Resistance

307.00

Second Support

291.00

Second Resistance

315.00

Third Support

283.00

Third Resistance

319.00

RSI

68.66

ADX

32.83

MACD

17.08

Williams % R

-26.07

Commodity Channel Index (CCI)

108.99

Date

2025-04-30

Week

10250.00

Same Day

8000.00

Month

4944.00

1 Year

0.78

3 Year

0.43

Over 1 Month

24.18%

down

Over 1 Year

34.90%

down

Over 3 Months

-2.36%

down

Over 3 Years

58.95%

down

Over 6 Months

-7.24%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

INFINIUM PHARMACHEM LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
34.76%
Promoter Holdings
65.23%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Pravin Bhadabhai Madhani 1901840.0 (12.2%) Shareholding of Promoter and Promoter Group
Sanjaykumar Viththalbhai Patel 1598000.0 (10.25%) Shareholding of Promoter and Promoter Group
Bhadabhai Kacharabhai Madhani 1492720.0 (9.58%) Shareholding of Promoter and Promoter Group
Lavjibhai Ramjibhai Chikhaliya 1184890.0 (7.6%) Shareholding of Promoter and Promoter Group
Varshaben Pravinbhai Madhani 1145840.0 (7.35%) Shareholding of Promoter and Promoter Group
Mitesh Lavjibhai Chikhaliya 744360.0 (4.78%) Shareholding of Promoter and Promoter Group
Ashish Kacholia 720000.0 (4.62%) Public Shareholding
Ashish Agarwal 720000.0 (4.62%) Public Shareholding
Daxa Sanjaykumar Patel 573000.0 (3.68%) Shareholding of Promoter and Promoter Group
Bharat Khodabhai Madhani 542660.0 (3.48%) Shareholding of Promoter and Promoter Group
Shardaben Lavjibhai Chikhaliya 311620.0 (2.0%) Shareholding of Promoter and Promoter Group
Dipen Babulal Dobariya 309000.0 (1.98%) Public Shareholding
Vinitkumar Maheshkumar Dobariya 291000.0 (1.87%) Public Shareholding
Mignesh Lavjibhai Chikhaliya 226660.0 (1.45%) Shareholding of Promoter and Promoter Group
Piyush Viththalbhai Chikhaliya 125880.0 (0.81%) Shareholding of Promoter and Promoter Group
Urvishaben Piyushbhai Chikhaliya 112910.0 (0.72%) Shareholding of Promoter and Promoter Group
Vitthalbhai Ramjibhai Chikhalia 67220.0 (0.43%) Shareholding of Promoter and Promoter Group
Varsha Virani 37200.0 (0.24%) Shareholding of Promoter and Promoter Group
Pratikshaben Lavjibhai Chikhaliya 37000.0 (0.24%) Shareholding of Promoter and Promoter Group
Krupaben Miteshbhai Chikhaliya 37000.0 (0.24%) Shareholding of Promoter and Promoter Group
Manjulaben Vitthalbhai Chikhalia 27320.0 (0.18%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

INFINIUM PHARMACHEM LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
13 Sep 2023 13 Sep 2023 1:1
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
13 Sep 2023 13 Sep 2023 1:1
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

INFINIUM PHARMACHEM LTD Share Price

Infinium Pharmachem Limited was originally incorporated as 'Infinium Pharmachem Private Limited' on November 21, 2003 issued by the Registrar of Companies, Gujarat. Later on, Company converted into Public Company and the name of Company was changed to 'Infinium Pharmachem Limited' vide fresh Certificate of Incorporation dated August 12, 2022 by the RoC, Gujarat.

Company was promoted initially by Sanjaykumar Viththalbhai Patel, Pravin Bhadabhai Madhani and others laid down the foundation of the Company in 2003 as a Private Limited in the name of 'M/s Infinium Pharmachem Private Limited' with a vision to establish itself as a globally integrated & admired Pharmaceutical & Healthcare Company. Later on they converted Private Limited into Public Limited Company in the name and style of 'M/s Infinium Pharmachem Limited (Infinium)'.

The Company was incorporated with the objective of manufacturing and supplying of various pharma related chemicals, bulk drugs, pharma intermediates etc. The Company is engaged in manufacturing and selling of Iodian based Pharmaceutical Intermediates . The Company has its manufacturing plant at Dist. Anand, Gujarat, since inception. The Company was formed with a vision to be globally integrated and admired Pharmaceutical & Healthcare Company,

The Company's manufacturing capabilities and technical expertise have catered industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics, etc. Apart from these, it provides a range of Iodine derivatives in the market, with more than 200 intermediates and over 7 APIs.

Later, in 2019, the Company formed a Joint Venture (JV) with Shanghai Witofly Chemical Co. Ltd., in the name of Shanghai Tajilin Industrial Co. Ltd., in the People's Republic of China. It also formed a Subsidiary Company in the name of Infinium Green Energy Private Limited on June 06, 2022.

The Company came up with a public issue of 18,75,000 Equity Shares of face value of Rs 10 each by raising funds aggregating to Rs 25.25 Crore in April, 2023.

The Company has commenced construction activities for its new Project dedicated to manufacturing contrast media raw materials on July 6, 2024 at Plot No. 1, GIDC Sojitra, Dist. Anand, Gujarat.

Parent organization Indian Private
NSE symbol INFINIUM
Founded 2003
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Infinium Pharmachem Ltd?

Answer Field

The share price of Infinium Pharmachem Ltd for NSE is ₹ 296.8 and for BSE is ₹ 0.00.

What is the Market Cap of Infinium Pharmachem Ltd?

Answer Field

The market cap of Infinium Pharmachem Ltd for NSE is ₹ 4,13.03 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Infinium Pharmachem Ltd?

Answer Field

The 52 Week High and Low of Infinium Pharmachem Ltd for NSE is ₹ 392.50 and ₹ 178.05 and for BSE is ₹ 0.00 and ₹ 0.00.

How to Buy Infinium Pharmachem Ltd share?

Answer Field

You can trade in Infinium Pharmachem Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Infinium Pharmachem Ltd?

Answer Field

The 1 year returns on the stock has been 34.90%.

What is the Current Share Price of Infinium Pharmachem Ltd?

Answer Field

Infinium Pharmachem Ltd share price is for NSE ₹ 296.8 & for BSE ₹ 0.00 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Infinium Pharmachem Ltd Share?

Answer Field

The market cap of Infinium Pharmachem Ltd for NSE ₹ 4,13.03 & for BSE ₹ 0.0 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Infinium Pharmachem Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Infinium Pharmachem Ltd share is 41.69.

What is the PB ratio of Infinium Pharmachem Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Infinium Pharmachem Ltd share is 63.43.

How to Buy Infinium Pharmachem Ltd Share?

Answer Field

You can trade in Infinium Pharmachem Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Infinium Pharmachem Ltd Share on Bajaj Broking App?

Answer Field

To buy Infinium Pharmachem Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Infinium Pharmachem Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|